Researchers will test whether the company's Genomic Prostate Score assay predicts disease progression and outcomes in a prospective cohort.

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer IRVINE, CA – January XX, 2026 (GlobeNewswire) ...

Mdxhealth (MDXH) announced the next major phase of its collaboration with the University of Oxford: the initiation of Genomic Prostate Score, GPS, ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.